02.12.2010 - U.S. pharmaceutical company Merck & Co. is set to buy SmartCells Inc, a privately held biotechnology firm in the early stages of developing a new diabetes drug, the Wall Street...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)